These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37336474)

  • 21. Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis.
    Weinberg EM; Palecki J; Reddy KR
    Semin Liver Dis; 2019 May; 39(2):195-208. PubMed ID: 30978730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism: A Systematic Review.
    Gómez-Outes A; Lecumberri R; Suárez-Gea ML; Terleira-Fernández AI; Monreal M; Vargas-Castrillón E
    J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):490-500. PubMed ID: 25802423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens.
    Trujillo-Santos J; Di Micco P; Dentali F; Douketis J; Díaz-Peromingo JA; Núñez MJ; Cañas I; Mastroiacovo D; Saraiva de Sousa M; Monreal M;
    Thromb Haemost; 2017 Jan; 117(2):382-389. PubMed ID: 27786333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis.
    Ai MH; Dong WG; Tan XP; Xu L; Xu C; Zhang Q; Zhang Y; Li J
    Eur J Gastroenterol Hepatol; 2020 Oct; 32(10):1395-1400. PubMed ID: 32675774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
    Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
    Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer: a systematic review and meta-analysis.
    Dong Y; Wang Y; Ma RL; Liu M; Gao JZ; Su WY; Yan L; Sun JJ
    J Thromb Thrombolysis; 2019 Oct; 48(3):400-412. PubMed ID: 31062143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of venous thromboembolism in cancer patients: a systematic review and meta-analysis on the efficacy and safety of different direct oral anticoagulants (DOACs).
    Song X; Liu Z; Zeng R; Shao J; Liu B; Zheng Y; Liu C; Ye W
    Ann Transl Med; 2021 Jan; 9(2):162. PubMed ID: 33569464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis.
    Valeriani E; Di Nisio M; Riva N; Cohen O; Porreca E; Senzolo M; De Gottardi A; Magaz M; Garcia-Pagan JC; Ageno W
    Thromb Haemost; 2021 Jul; 121(7):867-876. PubMed ID: 33525037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct Oral Anticoagulant for the Treatment of VTE in Cancer Patients: A Systematic Review and Meta-analysis.
    Dong S; Zhang Y; Li Y; Li Y; Miao Y; Zhao R; Zhai S
    Ann Pharmacother; 2021 Apr; 55(4):430-439. PubMed ID: 32938202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer.
    Kirkilesis GI; Kakkos SK; Tsolakis IA
    Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis.
    Elsebaie MAT; van Es N; Langston A; Büller HR; Gaddh M
    J Thromb Haemost; 2019 Apr; 17(4):645-656. PubMed ID: 30690830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct oral anticoagulants versus standard anticoagulation in children treated for acute venous thromboembolism.
    Chen J; Bi G; Wu F; Qin X
    Pediatr Res; 2023 May; 93(6):1491-1498. PubMed ID: 36071237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism: A systematic review and Bayesian network meta-analysis.
    Ning H; Yang N; Ding Y; Chen H; Wang L; Han Y; Cheng G; Zou M
    Med Clin (Barc); 2023 Mar; 160(6):245-252. PubMed ID: 36031454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.
    La Mura V; Braham S; Tosetti G; Branchi F; Bitto N; Moia M; Fracanzani AL; Colombo M; Tripodi A; Primignani M
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1146-1152.e4. PubMed ID: 29066371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
    Alhousani M; Malik SU; Abu-Hashyeh A; Poznanski NJ; Al-Hasan S; Roth DF; Alsharedi M; Mustafa B
    Thromb Res; 2021 Feb; 198():103-114. PubMed ID: 33310644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic review and meta-analysis of anticoagulation therapy for portal vein thrombosis in patients with cirrhosis: to treat or not to treat?
    Dong S; Qi H; Li Y; Men P; Alifu M; Zhang Y; Li Y; Zhao R
    Hepatol Int; 2021 Dec; 15(6):1356-1375. PubMed ID: 34487316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis.
    Gao Y; Liu H; Tang F; Zhang X; Li F; Ye Q; Yuan H; Lv H; Han T
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101649. PubMed ID: 33601064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of intracranial hemorrhage with direct oral anticoagulation versus low molecular weight heparin in the treatment of brain tumor-associated venous thromboembolism: A meta-analysis.
    Yang J; He Z; Li M; Hong T; Ouyang T
    J Stroke Cerebrovasc Dis; 2023 Aug; 32(8):107243. PubMed ID: 37413715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct versus conventional anticoagulants for treatment of cancer associated thrombosis: a pooled and interaction analysis between observational studies and randomized clinical trials.
    Gu ZC; Yan YD; Yang SY; Shen L; Kong LC; Zhang C; Wei AH; Li Z; Wang XH; Lin HW
    Ann Transl Med; 2020 Feb; 8(4):95. PubMed ID: 32175388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Evidence-Based Approach to Anticoagulation Therapy Comparing Direct Oral Anticoagulants and Vitamin K Antagonists in Patients With Atrial Fibrillation and Bioprosthetic Valves: A Systematic Review, Meta-Analysis, and Network Meta-Analysis.
    Suppah M; Kamal A; Saadoun R; Baradeiya AMA; Abraham B; Alsidawi S; Sorajja D; Fortuin FD; Arsanjani R
    Am J Cardiol; 2023 Nov; 206():132-150. PubMed ID: 37703679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.